Subscribe to Newsletter

August 2019 Issue of The Cannabis Scientist

Antibiotic, antispasmodic and analgesic: we delve into the medical evidence surrounding cannabis compounds in our July edition, inviting a panel of experts from four different professions to give their two cents on cannabis for pain management in our cover feature “Perspectives on Pain”. Our contributors explore the need to accumulate scientific evidence to bring about changes in cannabis policy and changes in microbial testing of the plant, among other hot topics. This month’s Sitting Down With features John Abrams, Director of the Emerald Conference, as we discuss life in this booming field.

Register to download
Register here to download any issue of The Cannabis Scientist for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Cannabis Scientist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Business & Profession Legislation & policy

Cannabis Conversations

| Rich Whitworth

The need for open and ongoing discussion between scientists, clinicians, regulators, and patients has never been clearer.
Research & Development Addiction

Off the Hook?

| Jonathan James

Repurposing nabiximols to tackle cannabis dependency.
Research & Development Medical research

New Drugs for Stubborn Bugs

| Matthew Hallam

Novel antibacterial agents are needed… Could cannabidiol fill the void?
Testing & Processing Classification

Not as Advertised

| Matthew Hallam

Apples to oranges… to cannabis. Strain classifications in US dispensaries are not always what they appear.
Research & Development Medical research

Cannabis: the Fetal Position

| Jonathan James

Cannabis exposure during pregnancy could have adverse effects on brain development – but where is the data to prove it?
Business & Profession Legislation & policy

Knowledge is Power - and Progress

| Paul Mavor

Scientists must come together to share experiences, accumulate evidence, and bring about change in cannabis policy.
Testing & Processing Mycotoxin analysis

Culture Shock

| Kyle Boyar

Microbial safety: why viability testing fails to protect patients.
Business & Profession Legislation & policy

Taking Back Cannabis Control

| Reggie Gaudino

Ill-considered regulations have resulted in an analytical race to the bottom.
Research & Development Pain

Perspectives on Pain

| Jonathan James

From early-stage research to clinical practice, four experts offer their take on the potential of cannabis-based pain relief.

Pesticide Analysis in Oil-Based Cannabis Products using UCT's LipiFiltr®

| Contributed by UCT

Testing laboratories face the difficult task of removing a variety of unwanted matrix components from their samples prior to LC-MS or GC-MS analysis.
Business & Profession Business

Cannabinoid Collaborator

Sitting Down With… John Abrams, The Clinical Endocannabinoid System Consortium (CESC) and Abrams BioConsulting, San Diego, California, USA.

Other issues of 2019